Comera Life Sciences Holdings, Inc.
シンボルマーク: CMRA
NASDAQ
0.02684
USD今日の市場価格
-0.0074
PER（株価収益率
0.0000
PEGレシオ
1.17M
MRK キャップ
- 0.00%
DIV利回り
Comera Life Sciences Holdings, Inc. (CMRA) 財務諸表
貸借対照表
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 4.23 | 0.4 | 6.5 | 0.2 | |||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.net-receivables | 0.63 | 0 | 0.2 | 0.1 | |||
balance-sheet.row.inventory | 3.98 | 2.5 | 0 | 0 | |||
balance-sheet.row.other-current-assets | 1.08 | 0.1 | 0 | 0 | |||
balance-sheet.row.total-current-assets | 9.93 | 3.1 | 6.8 | 0.3 | |||
balance-sheet.row.property-plant-equipment-net | 1.84 | 0.6 | 0.6 | 0.2 | |||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.other-non-current-assets | 0.37 | 0.1 | 0.1 | 0.1 | |||
balance-sheet.row.total-non-current-assets | 2.21 | 0.7 | 0.6 | 0.2 | |||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-assets | 12.14 | 3.7 | 7.4 | 0.5 | |||
balance-sheet.row.account-payables | 6.53 | 1.5 | 0.4 | 0.1 | |||
balance-sheet.row.short-term-debt | 1.85 | 0.7 | 0.1 | 0.1 | |||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||
balance-sheet.row.long-term-debt-total | 0.17 | 0.1 | 0.2 | 0.2 | |||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||
balance-sheet.row.other-current-liab | 5.52 | 2.8 | 0 | 0 | |||
balance-sheet.row.total-non-current-liabilities | 18.92 | 4.9 | 21.1 | 0.2 | |||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||
balance-sheet.row.capital-lease-obligations | 0.98 | 0.3 | 0.3 | 0 | |||
balance-sheet.row.total-liab | 34.22 | 10 | 22.1 | 0.4 | |||
balance-sheet.row.preferred-stock | 13622.31 | 4517.7 | 20.9 | 0 | |||
balance-sheet.row.common-stock | 0.01 | 0 | 0 | 10.7 | |||
balance-sheet.row.retained-earnings | -152.04 | -34.9 | -16.9 | -11.4 | |||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -9017.78 | 0 | -20.9 | 0 | |||
balance-sheet.row.other-total-stockholders-equity | -4474.58 | -4489.1 | 2.2 | 0.9 | |||
balance-sheet.row.total-stockholders-equity | -22.08 | -6.2 | -14.7 | 0.2 | |||
balance-sheet.row.total-liabilities-and-stockholders-equity | 12.14 | 3.7 | 7.4 | 0.5 | |||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-equity | -22.08 | -6.2 | -14.7 | 0.2 | |||
balance-sheet.row.total-liabilities-and-total-equity | 12.14 | - | - | - | |||
Total Investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-debt | 2.02 | 0.8 | 0.3 | 0.2 | |||
balance-sheet.row.net-debt | -2.2 | 0.3 | -6.2 | 0 |
キャッシュフロー計算書
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -9.01 | -18 | -5.5 | -2.1 | |||
cash-flows.row.depreciation-and-amortization | 0.1 | 0.1 | 0.1 | 0.1 | |||
cash-flows.row.deferred-income-tax | -0.08 | 0 | -0.2 | 0 | |||
cash-flows.row.stock-based-compensation | 1 | 0.4 | 1.1 | 0.1 | |||
cash-flows.row.change-in-working-capital | 1.41 | 2.6 | 0.6 | 0 | |||
cash-flows.row.account-receivables | 0.29 | 0 | 0.1 | -0.1 | |||
cash-flows.row.inventory | 0.51 | 0 | 0.2 | 0.1 | |||
cash-flows.row.account-payables | -0.4 | 0.9 | 0.3 | 0 | |||
cash-flows.row.other-working-capital | 1 | 1.7 | 0 | 0 | |||
cash-flows.row.other-non-cash-items | -0.08 | 5.2 | 0.1 | 0.2 | |||
cash-flows.row.net-cash-provided-by-operating-activities | -6.66 | 0 | 0 | 0 | |||
cash-flows.row.investments-in-property-plant-an-equipment | -28.68 | 0 | -0.1 | 0 | |||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||
cash-flows.row.other-investing-activites | 0.01 | 0 | 0 | 0 | |||
cash-flows.row.net-cash-used-for-investing-activites | -28.66 | 0 | -0.1 | 0 | |||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | |||
cash-flows.row.common-stock-issued | 0.13 | 0.8 | 0 | 1.4 | |||
cash-flows.row.common-stock-repurchased | 650 | 650 | 0 | 0 | |||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||
cash-flows.row.other-financing-activites | -644.28 | -645.6 | 10.3 | 0.2 | |||
cash-flows.row.net-cash-used-provided-by-financing-activities | 5.85 | 5.2 | 10.3 | 1.6 | |||
cash-flows.row.effect-of-forex-changes-on-cash | 28.57 | 0 | 0 | 0 | |||
cash-flows.row.net-change-in-cash | -0.9 | -4.6 | 6.4 | -0.3 | |||
cash-flows.row.cash-at-end-of-period | 5.94 | 2 | 6.6 | 0.2 | |||
cash-flows.row.cash-at-beginning-of-period | 6.84 | 6.6 | 0.2 | 0.4 | |||
cash-flows.row.operating-cash-flow | -6.66 | -9.8 | -3.8 | -1.8 | |||
cash-flows.row.capital-expenditure | -28.68 | 0 | -0.1 | 0 | |||
cash-flows.row.free-cash-flow | -35.34 | -9.8 | -3.9 | -1.8 |
損益計算書の行
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1 | 0.6 | 0.3 | 0.4 | |||
income-statement-row.row.cost-of-revenue | 0.26 | 0.2 | 0.2 | 0.1 | |||
income-statement-row.row.gross-profit | 0.74 | 0.4 | 0.2 | 0.3 | |||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||
income-statement-row.row.research-development | 1.43 | - | - | - | |||
income-statement-row.row.selling-general-administrative | 8.45 | - | - | - | |||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||
income-statement-row.row.other-expenses | 0 | -1.5 | -0.1 | 0 | |||
income-statement-row.row.operating-expenses | 9.88 | 12.4 | 5.7 | 2.5 | |||
income-statement-row.row.cost-and-expenses | 10.15 | 12.6 | 5.9 | 2.6 | |||
income-statement-row.row.interest-income | 0.03 | 0 | 0 | 0 | |||
income-statement-row.row.interest-expense | 0.03 | 0 | 0 | 0 | |||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||
income-statement-row.row.total-other-income-expensenet | 0.15 | -6 | 0.1 | 0 | |||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||
income-statement-row.row.other-operating-expenses | 0 | -1.5 | -0.1 | 0 | |||
income-statement-row.row.total-operating-expenses | 0.15 | -6 | 0.1 | 0 | |||
income-statement-row.row.interest-expense | 0.03 | 0 | 0 | 0 | |||
income-statement-row.row.depreciation-and-amortization | 0.1 | -1.4 | -0.1 | 0.1 | |||
income-statement-row.row.ebitda-caps | -9.07 | - | - | - | |||
income-statement-row.row.operating-income | -9.15 | -12 | -5.5 | -2.1 | |||
income-statement-row.row.income-before-tax | -9.01 | -18 | -5.5 | -2.1 | |||
income-statement-row.row.income-tax-expense | 75.23 | 6 | -0.2 | 0 | |||
income-statement-row.row.net-income | -84.25 | -24 | -5.3 | -2.1 |
よくある質問
Comera Life Sciences Holdings, Inc.CMRA 総資産とは何ですか？
Comera Life Sciences Holdings, Inc. (CMRA) 総資産は 3727113.000.
企業の年間売上高とは？
年間収益は 451365.000である.
企業の利益率は？
利益率は 0.735 である.
企業のフリーキャッシュフローとは？
フリーキャッシュフローは -1.529.
企業の純利益率は？
純利益率は -84.219 である.
企業の総収入は？
総収入は -9.143 である.
Comera Life Sciences Holdings, Inc. (CMRA) 純利益（純利益）とは何ですか？
純利益（純利益）は -24038181.000.
負債総額は？
負債合計は 775048.000 である.
営業費用はいくらですか？
営業費用は 12392727.000 である.
会社の現金はいくらですか？
企業の現金は 1767870.000 である.